Risperdal Consta Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)
Condition:   Schizophrenia Interventions:   Drug: MK-8189;   Drug: Risperidone;   Drug: Placebo to MK-8189;   Drug: Placebo to risperidone Sponsor:   Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2020 Category: Research Source Type: clinical trials